DAFTRA PUSTAKA

Ariani, Cindy. 2012. Kadar Profil Lipid Serum sebagai salah satu faktor pada
kejadian Psoriasis. Thesis Univeristas Udayana Bali.

Badan POM RI. IONI. Informatorium Obat Nasional Indonesia. 2008.

Berger, Timothy G., 2007. Skin, Hair, & Nails. In: McPhee, Stephen J.,
Papadaxis, Maxine A., Tierney, Lawrence M. CURRENT Medical
Diagnosis & Treatment.46th Edition. San Francisco, California:
McGraw-Hills.109-111.

Departemen Kesehatan RI. Buku pedoman nasional pengendalian penyakit kusta.

Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. 2007.
Ditjen PPM dan PL Depkes RI. Statistik Kasus HIV/AIDS di Indonesia. Dilapor 1
April s.d 30 juni 2011. Availabel from : http://spirita.or.id/StatsCur,pdf.
[ Accesed 22 Juni 2017]
Djuanda, Adhi. 2011. Ilmu Penyakit Kulit dan Kelamin Edisi keenam. Badan
penerbit Fakultas Kedokteran Universitas Indonesia. Jakarta.

Dodds, Hawke CI. Linezolid versus vancomycin for MRSAskin and soft tissue
infections (Systematic Review and Meta-Analysis). ANZ J Surg.
2009;79: 629-35

Freddberg IM, Elsen AZ, Wolff K, et al: Fitzpatricks Dermatology General

Medicine, 7th edition. New York: McGraw-Hill, 2008.

Ganiswara SG. Farmakologi dan Terapi edisi 4. Jakarta: Bagian Farmakologi

FKUI; 1995.

Ganiswarna G Sulistia. 1995. Farmakologi dan Terapi. Edisi 4. Jakarta : Balai

Penerbit FKUI

Gould FK, Brindle R, Chadwick PR, Fraise AP, Hill S,Nathwani D, dkk.
Guidelines (2008) for the prophylaxis andtreatment of Methicillin
resistant Staphylococcus aureus(MRSA) infections in the United
Kingdom. J AntimicrobChemother. 2009; 63: 848-61

Kosasih A, Wisnu IM, Sjamsoe-Daili ES, Menaldi SL.Kusta. Dalam: Adhi

Djuanda. (ed). Ilmu penyakit kulit dan kelamin edisi 6. Jakarta:Badan
Penerbit FKUI;2013.p.73-88.
Leto MGP, Santor Jr GF, Poro AM, Tomimori J. Human papillomavirus
infection: etiopathogenesis, molecular biology and clinical
manifestations. An Bras Dermatol. 2011; 86(2): 306-17.

Levine DP. Therapy for community-associated MRSAinfections: antibiotics and

more. CID.2008; 9: 1-6.

Liu C, Bayer A, Cosgorove SE, Daum RS, Fridkin SK, GorwitzRJ, dkk. Clinical
practice guidelines by the infectious diseasessociety of America for the
treatment of Methicillin-resistantStaphylococcus aureus infections in
adults and children:executive summary. 2011; 52: 285-92.

Livermore DM. Linezolid in vitro: mechanism and antibacterialspectrum. J

Antimicrob Chemother. 2003; 51: 9-16LD.

Movita, Theresia. 2013. Acne Vulgaris. Cermin Dunnia Kedokteran Volume 40

nomor 3 tahun 2013. Hal. 269-271.

Psoriasis Dwinidya Yuliastuti RS Meilia, Cibubur, Depok, Indonesia. CDK-235/

vol. 42 no. 12, th. 2015
Reed RL. Antibiotics for MRSA Infections. Dalam: WeigeltJA, penyunting.
MRSA. New York: Informa Healthcare;2007.h. 147-63.

Ronny P. Handoko. 2010. Buku Ajar Ilmu Penyakit Kulit dan Kelamin : Herpes
Simpleks. Jakarta: Balai Pustaka FKUI. Ed 6. Hal 380.

Rosmelia. 2010. Dasar-Dasar Diagnosis Dalam Dermatologi. Fakultas

Kedokteran Universitas Islam Indonesia. Yogyakarta.

Shaw, James C., 2006. Herpes Simplex. In: Frankel, David H. Field Guide to
Clinical Dermatology. 2nd edition. Brooklyn, New York: Lippincott Williams &
Wilkins. 74-75.

Sibagariang, E. E., Pusmaika, R., & Rismalinda. 2010. Kesehatan Reproduksi

Perempuan. Jakarta: Trans Info Media.
Siregar, R.S. 2005. Atlas Berwarna Saripati Penyakit Kulit Edisi 2. EGC. Jakarta.

Smith SM, Eng RHK, Tumang FT. Ciprofloxacin therapy forMethicillin resistant
Staphylococcus aureus infections orcolonization. Antimicrob Agents
Chemother. 1989; 33: 181-4

Sterry, W., Paus, R., Burgdorf, W., 2006.Viral Diseases. In: Thieme Clinical
Companions Dermatology. New York: Thieme. 57-60.4.
WHO. Leprosy elimination: classification of leprosy.
http://www.who.int/lep/classification/en/index.html
World Health Organization. WHO Expert committee on leprosy, eighth report.
WHO Technical Report Series. 2012.